Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1)

Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in patients with asthma suggest that BHR to adenosine 5'-monophosphate (AMP) is a better marker of bronchial inflammation than BHR to methacholine. The association between markers of airway inflammatio...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 165; no. 3; p. 327
Main Authors De Meer, Gea, Heederik, Dick, Postma, Dirkje S
Format Journal Article
LanguageEnglish
Published United States 01.02.2002
Subjects
Online AccessGet full text
ISSN1073-449X
DOI10.1164/ajrccm.165.3.2104066

Cover

Abstract Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in patients with asthma suggest that BHR to adenosine 5'-monophosphate (AMP) is a better marker of bronchial inflammation than BHR to methacholine. The association between markers of airway inflammation and BHR to methacholine and AMP in a population of young adults, with mild symptoms if any, was evaluated. A total of 230 subjects who participated in a follow-up study on occupational allergy were included. Before exposure to occupational allergens, subjects completed a questionnaire on respiratory symptoms and were tested for atopy, blood eosinophilia (> or =275/mm(3)), and BHR to methacholine and AMP (> or =15% fall in FEV(1)). Risk estimates were expressed as prevalence ratios (PR) and 95% confidence intervals (95% CI). Dose-response slopes (DRS) for methacholine and AMP were compared between healthy control subjects, self-reported allergic rhinitis, and allergic asthma. BHR to AMP was associated with allergic rhinitis (PR 2.51, 95% CI: 1.22;5.17), allergic asthma (PR 4.38, 95% CI: 1.98;9.66), with atopy (PR 3.87, 95% CI: 1.76;8.52), and blood eosinophilia (PR 3.57, 95% CI: 1.48;8.77), but not with baseline FEV(1). BHR to methacholine was inversely related to prechallenge FEV(1) (PR 0.97, 95% CI: 0.96;0.99). For both methacholine and AMP the geometric mean DRS increased along the axis asymptomatic-allergic rhinitis-allergic asthma, but for AMP the increase was the strongest. In this population study among young adults, BHR to AMP refers to allergic background of airway lability and BHR to methacholine is related to a diminished airway caliber.
AbstractList Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in patients with asthma suggest that BHR to adenosine 5'-monophosphate (AMP) is a better marker of bronchial inflammation than BHR to methacholine. The association between markers of airway inflammation and BHR to methacholine and AMP in a population of young adults, with mild symptoms if any, was evaluated. A total of 230 subjects who participated in a follow-up study on occupational allergy were included. Before exposure to occupational allergens, subjects completed a questionnaire on respiratory symptoms and were tested for atopy, blood eosinophilia (> or =275/mm(3)), and BHR to methacholine and AMP (> or =15% fall in FEV(1)). Risk estimates were expressed as prevalence ratios (PR) and 95% confidence intervals (95% CI). Dose-response slopes (DRS) for methacholine and AMP were compared between healthy control subjects, self-reported allergic rhinitis, and allergic asthma. BHR to AMP was associated with allergic rhinitis (PR 2.51, 95% CI: 1.22;5.17), allergic asthma (PR 4.38, 95% CI: 1.98;9.66), with atopy (PR 3.87, 95% CI: 1.76;8.52), and blood eosinophilia (PR 3.57, 95% CI: 1.48;8.77), but not with baseline FEV(1). BHR to methacholine was inversely related to prechallenge FEV(1) (PR 0.97, 95% CI: 0.96;0.99). For both methacholine and AMP the geometric mean DRS increased along the axis asymptomatic-allergic rhinitis-allergic asthma, but for AMP the increase was the strongest. In this population study among young adults, BHR to AMP refers to allergic background of airway lability and BHR to methacholine is related to a diminished airway caliber.
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in patients with asthma suggest that BHR to adenosine 5'-monophosphate (AMP) is a better marker of bronchial inflammation than BHR to methacholine. The association between markers of airway inflammation and BHR to methacholine and AMP in a population of young adults, with mild symptoms if any, was evaluated. A total of 230 subjects who participated in a follow-up study on occupational allergy were included. Before exposure to occupational allergens, subjects completed a questionnaire on respiratory symptoms and were tested for atopy, blood eosinophilia (> or =275/mm(3)), and BHR to methacholine and AMP (> or =15% fall in FEV(1)). Risk estimates were expressed as prevalence ratios (PR) and 95% confidence intervals (95% CI). Dose-response slopes (DRS) for methacholine and AMP were compared between healthy control subjects, self-reported allergic rhinitis, and allergic asthma. BHR to AMP was associated with allergic rhinitis (PR 2.51, 95% CI: 1.22;5.17), allergic asthma (PR 4.38, 95% CI: 1.98;9.66), with atopy (PR 3.87, 95% CI: 1.76;8.52), and blood eosinophilia (PR 3.57, 95% CI: 1.48;8.77), but not with baseline FEV(1). BHR to methacholine was inversely related to prechallenge FEV(1) (PR 0.97, 95% CI: 0.96;0.99). For both methacholine and AMP the geometric mean DRS increased along the axis asymptomatic-allergic rhinitis-allergic asthma, but for AMP the increase was the strongest. In this population study among young adults, BHR to AMP refers to allergic background of airway lability and BHR to methacholine is related to a diminished airway caliber.Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in patients with asthma suggest that BHR to adenosine 5'-monophosphate (AMP) is a better marker of bronchial inflammation than BHR to methacholine. The association between markers of airway inflammation and BHR to methacholine and AMP in a population of young adults, with mild symptoms if any, was evaluated. A total of 230 subjects who participated in a follow-up study on occupational allergy were included. Before exposure to occupational allergens, subjects completed a questionnaire on respiratory symptoms and were tested for atopy, blood eosinophilia (> or =275/mm(3)), and BHR to methacholine and AMP (> or =15% fall in FEV(1)). Risk estimates were expressed as prevalence ratios (PR) and 95% confidence intervals (95% CI). Dose-response slopes (DRS) for methacholine and AMP were compared between healthy control subjects, self-reported allergic rhinitis, and allergic asthma. BHR to AMP was associated with allergic rhinitis (PR 2.51, 95% CI: 1.22;5.17), allergic asthma (PR 4.38, 95% CI: 1.98;9.66), with atopy (PR 3.87, 95% CI: 1.76;8.52), and blood eosinophilia (PR 3.57, 95% CI: 1.48;8.77), but not with baseline FEV(1). BHR to methacholine was inversely related to prechallenge FEV(1) (PR 0.97, 95% CI: 0.96;0.99). For both methacholine and AMP the geometric mean DRS increased along the axis asymptomatic-allergic rhinitis-allergic asthma, but for AMP the increase was the strongest. In this population study among young adults, BHR to AMP refers to allergic background of airway lability and BHR to methacholine is related to a diminished airway caliber.
Author Heederik, Dick
De Meer, Gea
Postma, Dirkje S
Author_xml – sequence: 1
  givenname: Gea
  surname: De Meer
  fullname: De Meer, Gea
  email: G.demeer@iras.uu.nl
  organization: Institute for Risk Assessment Sciences, Division of Environmental and Occupational Health, Utrecht University, P.O. Box 80176, 3508 TD Utrecht, The Netherlands. G.demeer@iras.uu.nl
– sequence: 2
  givenname: Dick
  surname: Heederik
  fullname: Heederik, Dick
– sequence: 3
  givenname: Dirkje S
  surname: Postma
  fullname: Postma, Dirkje S
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11818315$$D View this record in MEDLINE/PubMed
BookMark eNo10LlOxDAQxnEXIO43QMgVR5HFEzuJUwJaDgkEBSC61cSZEKPEDnaW1b4GT8xyVdP851d822zNeUeM7YOYAOTqFN-CMf0E8mwiJykIJfJ8jW2BKGSiVPmyybZjfBMCUg1ig20CaNASsi32eR68M63FjgeKg3fRfpCjGPnoOdbkfLSOeHaU9N75ofVxaHEkfnx293DC0dW8p7FF0_ruu6tt01Dg1vGxJRtWZoejXamtHfjCji1HGxa45Nh1FF6XP0KFkX6-L6fPx3Cyy9Yb7CLt_d0d9nQ5fby4Tm7vr24uzm6TAWQ5JlWmyYDACnIiREwJsozKSmVGaqFUIXRZ5rmqoTGlSnWjq7yopDBUKii0ljvs8Ncdgn-fUxxnvY2Gug4d-XmcFaAglQpW4cFfOK96qmdDsD2G5ex_RfkFxYd3UA
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1164/ajrccm.165.3.2104066
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 11818315
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
-~X
.55
.GJ
0R~
1CY
1KJ
23M
2WC
34G
39C
3O-
53G
5GY
5RE
7RV
7X7
8C1
AAWTL
ABJNI
ABOCM
ABPMR
ACBNA
ACGFO
ACGFS
ADBBV
AENEX
AFCHL
AFFNX
AHMBA
AI.
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BENPR
C45
CGR
CS3
CUY
CVF
DIK
E3Z
EBS
ECM
EIF
EJD
EX3
F5P
FRP
GX1
H13
HZ~
IH2
J5H
KQ8
L7B
M5~
N4W
NPM
O9-
OBH
OFXIZ
OGEVE
OK1
OVD
OVIDX
P2P
RPM
SJN
TEORI
THO
TR2
VH1
VXZ
W8F
WH7
WOQ
WOW
X7M
ZE2
ZGI
ZXP
~02
7X8
ID FETCH-LOGICAL-p139t-b58ec10ab16eeaaa2e155e9b45c3804470899664d1fc9428f8b67b30ce9417883
ISSN 1073-449X
IngestDate Fri Sep 05 13:05:11 EDT 2025
Wed Feb 19 01:54:43 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p139t-b58ec10ab16eeaaa2e155e9b45c3804470899664d1fc9428f8b67b30ce9417883
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 11818315
PQID 71412341
PQPubID 23479
ParticipantIDs proquest_miscellaneous_71412341
pubmed_primary_11818315
PublicationCentury 2000
PublicationDate 2002-Feb-01
20020201
PublicationDateYYYYMMDD 2002-02-01
PublicationDate_xml – month: 02
  year: 2002
  text: 2002-Feb-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle American journal of respiratory and critical care medicine
PublicationTitleAlternate Am J Respir Crit Care Med
PublicationYear 2002
References 11818311 - Am J Respir Crit Care Med. 2002 Feb 1;165(3):317-8
References_xml – reference: 11818311 - Am J Respir Crit Care Med. 2002 Feb 1;165(3):317-8
SSID ssj0012810
Score 2.032516
Snippet Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in patients with asthma suggest that BHR to adenosine...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 327
SubjectTerms Adenosine Monophosphate
Adult
Bronchial Hyperreactivity - diagnosis
Bronchial Provocation Tests
Bronchoconstrictor Agents
Female
Forced Expiratory Volume - drug effects
Humans
Male
Methacholine Chloride
Middle Aged
Occupational Diseases - diagnosis
Respiratory Hypersensitivity - physiopathology
Title Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1)
URI https://www.ncbi.nlm.nih.gov/pubmed/11818315
https://www.proquest.com/docview/71412341
Volume 165
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuFW8orz2AaIUcvPb6daxo0gg1hUOCcrN27bWaotqR4wjBz-DA72Vmd-26EMTjYkVW1rZ2Ps3O8xtCXqjEzfPAl44qXN_hQeE7iSgSJymEdCMvzz3dSDs9DSdz_m4RLAaD772qpU0jh9nXrX0l_yNVuAdyxS7Zf5Bs91C4Ab9BvnAFCcP1r2QMPnSJtcrIzW9KXa3qAoNS5EgDjjZk8NKLHPimanVWrVdnYFyiWXk4_YARAYyb4xRpHJqiLU4zMcWWPy5r2-xiq7pMJ9yy_iy-vMYhLLWlb8KzUK8ejz4i81MbX2jpbdu0UI-nou7l-HVvXTtzQdei_ZzyPwLtowy6jlV3kkwUUmEstUI_aun9Uc9X6-bCJLKW9adzZeO7bXDDa-uhO30MGsjhXE_bvVTYZrqERabfU7--4Rn49VgIOZ5553WWXQxh-dAfgqsLtswWFu7T9-l4fnKSzkaL2TVy3Ysinf4_XnSlQ5h8NCwX9uNsSya85c22d_zeedFGzOwW2bXeBz00ULpNBqq8Q25M7WbfJd86RNGriKJNRTtE0eDVVTzRfUDTAQUx0j6WqMESXZZUY4n2sUQRS9RgiVos6Se0WKKApX12cI_Mx6PZ24ljp3Y4K_AmGkcGscqYKyQLlRJCeApMVpVIHmR-7HIeYaI5DHnOiiwB57eIZRhJ381UwlkUx_59slNWpXpIqGIi8ZTnxSISPJRMcBnkAhwcmRRwrrBH5Hm7sSloRUx1iVJVm3UaMQ4mGYd_PDD7na4MeUuKjdaxz4K9P659TG5eQvIJ2WnqjXoKFmgjn2k4_ABgc4wq
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bronchial+responsiveness+to+adenosine+5%27-monophosphate+%28AMP%29+and+methacholine+differ+in+their+relationship+with+airway+allergy+and+baseline+FEV%281%29&rft.jtitle=American+journal+of+respiratory+and+critical+care+medicine&rft.au=De+Meer%2C+Gea&rft.au=Heederik%2C+Dick&rft.au=Postma%2C+Dirkje+S&rft.date=2002-02-01&rft.issn=1073-449X&rft.volume=165&rft.issue=3&rft.spage=327&rft_id=info:doi/10.1164%2Fajrccm.165.3.2104066&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-449X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-449X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-449X&client=summon